MORGAN STANLEY - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 53 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,840
-81.7%
1,000
-83.3%
0.00%
Q2 2023$15,527
-93.2%
5,972
-95.2%
0.00%
Q1 2023$227,869
+356.2%
125,203
+313.6%
0.00%
Q4 2022$49,949
-62.4%
30,272
-56.3%
0.00%
Q3 2022$133,000
-79.4%
69,334
-67.8%
0.00%
Q2 2022$645,000
+7.5%
215,373
+35.2%
0.00%
Q1 2022$600,000
-39.5%
159,350
+82.8%
0.00%
Q4 2021$992,000
+1671.4%
87,191
+2634.1%
0.00%
Q3 2021$56,000
+5500.0%
3,189
+4455.7%
0.00%
Q2 2021$1,000700.00%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,474,572$9,329,0007.10%
Novo Holdings A/S 4,840,413$18,248,0000.96%
RA Capital Management 3,350,506$12,631,0000.28%
Avidity Partners Management LP 1,850,000$6,975,0000.14%
ACT CAPITAL MANAGEMENT, LLC 15,000$57,0000.06%
Baker Brothers Advisors 812,640$3,064,0000.02%
CAAS CAPITAL MANAGEMENT LP 105,091$396,0000.02%
Evercore Wealth Management, LLC 146,676$553,0000.01%
Jump Financial, LLC 21,300$80,0000.00%
JANUS HENDERSON GROUP PLC 1,719,610$6,486,0000.00%
View complete list of CYTEIR THERAPEUTICS INC shareholders